Mark Noe

Clinical Board Member at Entasis Therapeutics

Mark Noe, Ph.D., is Vice President of the Groton Center of Chemistry Innovation, an interdisciplinary department comprised of structural biology, analytical chemistry, synthesis technology, experimental design and computational analysis supporting Worldwide Medicinal Chemistry. In addition to his scientific leadership, Dr. Noe leads a number of supporting teams within Pfizer Research and Development, including Academic and Industry Relations for the chemistry discipline. He serves on multiple external scientific advisory panels for both academia and the biotechnology industry. Dr. Noe received his Ph.D. in organic chemistry from Harvard University.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Entasis Therapeutics

Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients.


Industries

Employees

11-50

Links